GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (NSE:ERIS) » Definitions » Cyclically Adjusted PB Ratio

Eris Lifesciences (NSE:ERIS) Cyclically Adjusted PB Ratio : 14.14 (As of Jul. 02, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Cyclically Adjusted PB Ratio?

As of today (2025-07-02), Eris Lifesciences's current share price is ₹1676.60. Eris Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₹118.59. Eris Lifesciences's Cyclically Adjusted PB Ratio for today is 14.14.

The historical rank and industry rank for Eris Lifesciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

NSE:ERIS' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 11.13   Med: 12.59   Max: 15.14
Current: 14.17

During the past years, Eris Lifesciences's highest Cyclically Adjusted PB Ratio was 15.14. The lowest was 11.13. And the median was 12.59.

NSE:ERIS's Cyclically Adjusted PB Ratio is ranked worse than
95.44% of 746 companies
in the Drug Manufacturers industry
Industry Median: 1.99 vs NSE:ERIS: 14.17

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eris Lifesciences's adjusted book value per share data for the three months ended in Mar. 2025 was ₹209.628. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹118.59 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eris Lifesciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Eris Lifesciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Cyclically Adjusted PB Ratio Chart

Eris Lifesciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 11.95

Eris Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 11.95

Competitive Comparison of Eris Lifesciences's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eris Lifesciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's Cyclically Adjusted PB Ratio falls into.


;
;

Eris Lifesciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Eris Lifesciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1676.60/118.59
=14.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eris Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Eris Lifesciences's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=209.628/157.5517*157.5517
=209.628

Current CPI (Mar. 2025) = 157.5517.

Eris Lifesciences Quarterly Data

Book Value per Share CPI Adj_Book
201303 7.715 85.687 14.185
201403 12.837 91.425 22.122
201503 19.321 97.163 31.329
201603 23.334 102.518 35.860
201606 0.000 105.961 0.000
201609 0.000 105.961 0.000
201612 0.000 105.196 0.000
201703 41.246 105.196 61.774
201706 0.000 107.109 0.000
201709 53.140 109.021 76.795
201712 0.000 109.404 0.000
201803 62.641 109.786 89.895
201806 0.000 111.317 0.000
201809 74.141 115.142 101.449
201812 0.000 115.142 0.000
201903 83.662 118.202 111.513
201906 0.000 120.880 0.000
201909 96.268 123.175 123.135
201912 0.000 126.235 0.000
202003 95.472 124.705 120.619
202006 0.000 127.000 0.000
202009 104.429 130.118 126.447
202012 0.000 130.889 0.000
202103 116.100 131.771 138.815
202106 0.000 134.084 0.000
202109 126.965 135.847 147.251
202112 0.000 138.161 0.000
202203 140.389 138.822 159.330
202206 0.000 142.347 0.000
202209 149.049 144.661 162.331
202212 0.000 145.763 0.000
202303 161.479 146.865 173.230
202306 0.000 150.280 0.000
202309 177.291 151.492 184.383
202312 0.000 152.924 0.000
202403 190.117 153.035 195.729
202406 0.000 155.789 0.000
202409 203.626 157.882 203.200
202412 0.000 158.323 0.000
202503 209.628 157.552 209.628

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eris Lifesciences  (NSE:ERIS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Eris Lifesciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eris Lifesciences Business Description

Traded in Other Exchanges
Address
Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences Headlines

No Headlines